Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to -$4.9 million.

  • Kewaunee Scientific's Change in Accured Expenses fell 50696.52% to -$4.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$1.9 million, marking a year-over-year decrease of 23455.68%. This contributed to the annual value of $583000.0 for FY2025, which is 1562.95% down from last year.
  • As of Q4 2025, Kewaunee Scientific's Change in Accured Expenses stood at -$4.9 million, which was down 50696.52% from -$1.5 million recorded in Q3 2025.
  • Over the past 5 years, Kewaunee Scientific's Change in Accured Expenses peaked at $7.5 million during Q1 2022, and registered a low of -$5.1 million during Q3 2024.
  • In the last 5 years, Kewaunee Scientific's Change in Accured Expenses had a median value of $249000.0 in 2021 and averaged $67850.0.
  • In the last 5 years, Kewaunee Scientific's Change in Accured Expenses soared by 150802.24% in 2022 and then plummeted by 216238.94% in 2024.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Change in Accured Expenses stood at $2.1 million in 2021, then crashed by 304.82% to -$4.3 million in 2022, then decreased by 3.24% to -$4.4 million in 2023, then surged by 127.2% to $1.2 million in 2024, then crashed by 506.97% to -$4.9 million in 2025.
  • Its Change in Accured Expenses stands at -$4.9 million for Q4 2025, versus -$1.5 million for Q3 2025 and $5.5 million for Q2 2025.